Susan Hasty, Publisher
Table of Contents . . . May 11th, 1998Non-Subscriber - Summaries Only
Conference Coverage (CHI Vaccines) - Tumor Vaccines: Breaking Self Tolerance Seen As Key
AIDS Vaccines - NYVAC-SIV Protects Against Virulent SIVmac251
Conference Coverage (ASM) - Vaccine Targets Vancomycin-Resistant Bacteria
Conference Coverage (CHI Vaccines) - Ulcer Vaccine Vectored by Cholera, Typhoid Bacteria
Influenza - 1997-8 Flu Vaccine May Have Missed Major Variant
Immunity (HBV) - Anti-HBc Does Not Preclude Hepatitis B Vaccination
Pediatrics (Influenza) - Nasal Spray Flu Vaccine Produces Local Antibody Response
Pediatrics (Vaccination) - Rural Clinicians Refer More Children to Public Immunization Clinics
TB Vaccine - New Tuberculosis Vaccine Candidate Developed
Vaccine Delivery - Murine Study Finds Mucosal Vaccine Useful for STDs
Vaccine Development - First Human Trial Shows that an Edible Vaccine Is Feasible
Cancer Vaccines (Theratope) - Bridging Study Leading To Pivotal Phase III Trial Announced
Education and Prevention - Leaders Unite to Battle Chronic Viral Hepatitis
India, Public Health - Biotech Helps Solve India's Health Problems
Influenza Vaccines - Phase I Clinical Trial on Nasally-Delivered Vaccine Begins
Malaria Vaccines - Phase I DNA Vaccine Trial Yields First Data in Man
Staphylococcus Vaccines - Pivotal Clinical Trial on Anti-Staph Vaccine Begin
Upcoming Meeting - Enterococcal Vaccine Featured at American Society for Microbiology
DNA Vaccines (Measles) - "Factors Determining Antibody Isotype in Measles Virus DNA Vaccination."
Bacterial Infection - "Intranasal Administration of a Meningococcal Outer Membrane Vesicle Vaccine Induces Persistent Local Mucosal Antibodies and Serum Antibodies With Strong Bactericidal Activity in Humans."
Vaccine Safety (SV40) - "Serological Evidence of SV40 Infections in HIV Infected and HIV Negative Adults."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.